Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3926 results

Sort By:

A Clinical Trial to Assess the Efficacy of AlphaWave® L-Theanine on Cognitive Function in Healthy Adults With Moderate Stress

Study ID: NCT07004023
Start Date: 2025-08
End Date: 2025-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

AlphaWave® L-Theanine

Placebo

Sponsor

Ethical Naturals, Inc.

Source: clinicaltrials.gov

Share:
Add to list

A Phase III Study of ESG401 for Unresectable Recurrent or Metastatic Triple-Negative Breast Cancer

Study ID: NCT06732323
Start Date: 2025-09
End Date: 2028-07
Study Type

Interventional

Study Phase

Phase3

No. of Participants

504

Intervention / Treatment

ESG401

Investigator's Choice Chemotherapy

Sponsor

Qilu Pharmaceutical Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

taVNS for Letter Learning in Dyslexia

Study ID: NCT06127550
Start Date: 2025-09-01
End Date: 2029-09-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

active taVNS

sham taVNS

Sponsor

University of Florida

Source: clinicaltrials.gov

Share:
Add to list

3D Scanning as an Advanced Tool for Identifying Tooth Lesions in Children

Study ID: NCT06829550
Start Date: 2025-08-01
End Date: 2026-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

indirect- 3D digital scanning

Sponsor

Indiana University

Source: clinicaltrials.gov

Share:
Add to list

Effects of Proactive Call to Customers of Norsk Rikstoto (Horse Gambling Operator in Norway): A Randomized Controlled Study

Study ID: NCT07028450
Start Date: 2025-10-01
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

192

Intervention / Treatment

Proactive call

Sponsor

University of Bergen

Source: clinicaltrials.gov

Share:
Add to list

Mitigate Immune-Mediated Loss of Therapeutic Response to Asfotase Alfa (STRENSIQ®) for Hypophosphatasia

Study ID: NCT06015750
Start Date: 2025-11-19
End Date: 2029-07-04
Study Type

Interventional

Study Phase

Phase4

No. of Participants

8

Intervention / Treatment

methotrexate

rituximab

bortezomib

IVIg

Folic Acid

Sponsor

Alexion Pharmaceuticals, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Coronary Sinus Reducer For The Management Of Symptomatic Heart Failure

Study ID: NCT07057323
Start Date: 2025-08
End Date: 2027-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

35

Intervention / Treatment

Coronary Sinus Reducer

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Assessment of Fall Risks and Subject-specific Training for Fall Reduction

Study ID: NCT06396650
Start Date: 2025-09
End Date: 2029-04-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Home-based training

Lab-based training

Sponsor

University of Maryland, Baltimore

Source: clinicaltrials.gov

Share:
Add to list

Spinal Cord Stimulation Pioneering Analgesia for Resilient Recovery in Post Intra-Thoracic Surgery Pain

Study ID: NCT06390150
Start Date: 2025-09
End Date: 2027-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

24

Intervention / Treatment

Spinal Cord Stimulation

Sponsor

Nova Scotia Health Authority

Source: clinicaltrials.gov

Share:
Add to list

Phase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab for Patients Refractory to Standard of Care Treatment and With Microsatellite-stable Colorectal Cancer

Study ID: NCT07011550
Start Date: 2025-11-30
End Date: 2030-07-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Nivolumab

Infinite

BMS-986340

Trifluridine + Tipiracil

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list